Literature DB >> 6226062

Putative atherogenic factors in patients with chronic renal failure.

D Green, N J Stone, F A Krumlovsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6226062     DOI： 10.1016/0033-0620(83)90027-0

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN： 0033-0620            Impact factor:   8.194


× No keyword cloud information.
  5 in total

1.  Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.

Authors:  G Feussner; J Bommer; R Ziegler
Journal:  Klin Wochenschr       Date:  1990-01-19

2.  Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.

Authors:  H Dieplinger; P Y Schoenfeld; C J Fielding
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

Review 3.  [Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].

Authors:  C J Olbricht
Journal:  Klin Wochenschr       Date:  1991-08-01

4.  Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis.

Authors:  G Feussner; S Wey; J Bommer; D Deppermann; P Grützmacher; R Ziegler
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

5.  Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine.

Authors:  Nelva T de Gómez Dumm; Ana M Giammona; Luis A Touceda
Journal:  Lipids Health Dis       Date:  2003-09-18       Impact factor: 3.876
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.